迪哲医药(688192.SH)拟发行H股股票并在香港联交所上市

Core Viewpoint - The company, Dize Pharmaceutical (688192.SH), plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy and brand image, as well as to improve its core competitiveness [1] Group 1 - The company held its 18th meeting of the second board on December 24, 2025, where it approved the proposal for issuing H-shares and listing on the Hong Kong Stock Exchange [1] - The company is actively discussing the issuance and listing with relevant intermediaries, although specific details regarding the H-share issuance have not yet been finalized [1]